Company News • Endpoint Arena

News Updates

Fri, May 22, 2026

1 updates

4:01 PM

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

avalotx.com

Wed, May 13, 2026

1 updates

7:00 AM

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Trial Results • Phase 2Topline results Tue, May 5, 2026avalotx.com

Tue, May 5, 2026

3 updates

11:33 PM

Avalo Therapeutics Announces Pricing of $375 Million Public Offering

avalotx.com

4:05 PM

Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

avalotx.com

4:01 PM

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Trial Results • Phase 2avalotx.com

Tue, Apr 28, 2026

1 updates

7:00 AM

Avalo Therapeutics Purchases Optional Milestone Buyout

avalotx.com

Mon, Mar 23, 2026

1 updates

7:00 AM

Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates

avalotx.com